39 Results for "

Akt 1 kinase

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "Akt 1 kinase" in MCE Product Catalog:

91
91 Publications Verification
Cat. No.: HY-15431
CAS No.: 1143532-39-1
Purity:  99.95%
Synonyms: AZD5363
Target:  

Akt Autophagy

Research Areas:  

Cancer

Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.
loading...
    loading...
42
42 Cited Publications
Cat. No.: HY-10249
CAS No.: 937174-76-0
Purity:  98.47%
Target:  

Akt AMPK Autophagy

Research Areas:  

Cancer

GSK-690693 is an ATP-competitive pan-Akt inhibitor with IC50s of 2 nM, 13 nM, 9 nM for Akt1, Akt2 and Akt3, respectively. GSK-690693 is also an AMPK inhibitor, affects Unc-51-like autophagy activating kinase 1 (ULK1) activity and robustly inhibits STING-dependent IRF3 activation .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-15727
CAS No.: 1047644-62-1
Purity:  99.53%
Synonyms: GSK2110183; LAE002
Target:  

Akt PKC ROCK

Research Areas:  

Cancer

Afuresertib (GSK2110183) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3, respectively .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-15727A
CAS No.: 1047645-82-8
Purity:  99.95%
Synonyms: GSK2110183 hydrochloride; LAE002 hydrochloride
Target:  

Akt PKC ROCK

Research Areas:  

Cancer

Afuresertib hydrochloride (GSK 2110183 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent pan-Akt kinase inhibitor with Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P80276
Synonyms: Akt 1 antibody; Akt antibody; Akt1 antibody; Akt1_HUMAN antibody; MGC99656 antibody; PKB antibody; PKB-ALPHA antibody; PRKBA antibody; Protein kinase B Alpha antibody; Protein kinase B antibody; Proto-oncogene c-Akt antibody; RAC Alpha antibody; RAC antibody; RAC-alpha serine/threonine-protein kinase antibody; RAC-PK-alpha antibody;

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P

Reactivity:  

Human, Mouse, Rat, Dog

loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P80788
Synonyms: Akt1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P86312
Synonyms: Akt antibody; Akt1 antibody; Akt1 kinase antibody; Akt1m antibody; Akt2 antibody; Akt2 kinase antibody; Akt3 antibody; Akt3_HUMAN antibody; CAkt antibody; CWS6 antibody; DKFZp434N0250 antibody; HIHGHH antibody; kinase Akt1 antibody; MGC99656 antibody; MPPH antibody; Murine thymoma viral (v-Akt) homolog 2 antibody; pan-Akt antibody

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16071
CAS No.: 1056901-62-2
Research Areas:  

Cancer

AT13148 is an orally active and ATP-competitive, multi-AGC kinase inhibitor with IC50s of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-137458
CAS No.: 1416775-46-6
Purity:  98.03%
Synonyms: ARQ 751
Target:  

Akt Ser/Thr Protease

Research Areas:  

Cancer

Vevorisertib (ARQ 751) is an orally active, potent and selective pan-AKT serine/threonine kinase inhibitor against AKT1 (IC50=0.55 nM), AKT2 (IC50=0.81 nM), and AKT3 (IC50=1.31 nM). Vevorisertib, as a single agent or in combination with other anti-cancer agents, can be used for the research of solid tumors with PIK3CA / AKT / PTEN mutations .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P80789
Synonyms: Akt1; PKB; RAC; RAC-alpha serine/threonine-protein kinase; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P702631
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: Akt1; Protein kinase B; Akt Serine/Threonine kinase 1; PKB Alpha; RAC; V-Akt Murine Thymoma Viral Oncogene-Like Protein 1 Isoform 2; PKB; V-Akt Murine Thymoma Viral Oncogene-Like Protein 1; RAC-Alpha Serine/Threonine-Protein kinase; Non-Specific Serine/Threonine Protein kinase; RAC-PK-Alpha; Akt1m Transcript Variant 3; RAC-Alpha; Akt1m Transcript Variant 4; PRKBA; Akt1m Transcript Variant 2; Akt; Akt1m Transcript Variant 1; V-Akt Murine Thymoma Viral Oncogene Homolog 1; Rac Protein kinase Alpha; Serine-Threonine Protein kinase; PKB-ALPHA; Protein kinase B Alpha; Akt1m; Proto-Oncogene C-Akt
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-N2902
CAS No.: 7608-44-8
Artocarpin is an orally active apoptosis inducer. Artocarpin targets NF-κB, Erk1/2, p38 MAPK, AktS473, p53, Akt 1 kinase and Akt 2 kinase. Artocarpin induces reactive oxygen species (ROS) production, mediates p53-dependent and p53-independent apoptotic signaling pathways, induces G1-phase cell cycle arrest, and triggers autophagic cell death. Artocarpin exerts cytotoxic and bactericidal effects on cancer cells, reduces bacterial load, and exhibits anti-inflammatory, analgesic and anti-angiogenic activities .
loading...
    loading...
Cat. No.: HY-E70786
Target:  

Akt

Research Areas:  

Cancer

AKT is the oncogenic protein kinase that regulates essential cellular functions such as migration, proliferation, differentiation, apoptosis, and metabolism. Mammalian cells are characterized by the expression of three different Akt isoforms, Akt1, Akt2, and Akt3. AKT1 E17K is a mutant of AKT1. AKT1 E17K Recombinant Human Active Protein Kinase is obtained by expressing AKT1 E17K proteins .
loading...
    loading...
Cat. No.: HY-126257
CAS No.: 2374740-21-1
Purity:  99.29%
Target:  

Akt Apoptosis

Research Areas:  

Cancer

AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells .
loading...
    loading...
Cat. No.: HY-15431R
CAS No.: 1143532-39-1
Synonyms: AZD5363 (Standard)
Research Areas:  

Cancer

Capivasertib (Standard) is the analytical standard of Capivasertib. This product is intended for research and analytical applications. Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1,Akt2 and Akt3, respectively.
loading...
    loading...
Cat. No.: HY-148868
CAS No.: 1334107-58-2
Target:  

Akt PKA CDK

Research Areas:  

Others

Akt1&PKA-IN-1 is a potent dual Akt/PKA inhibitor with IC50 values of 0.03 , 0.11 μM, and 9.8 μM for PKAa, Akt, and CDK2, respectively. Akt1&PKA-IN-1 is selective for cyclin-dependent kinase 2 (CDK2) .
loading...
    loading...
Cat. No.: HY-173122
CAS No.: 2247688-87-3
Target:  

Akt

Research Areas:  

Cancer

Akt1-IN-8 (Compound JL18) is a potent and oral bioavailable (41%) inhibitor of AKT1 kinase, with an IC50 of 8.8 nM. Akt1-IN-8 exhibits significant antiproliferative effects against PC-3 prostate cancer cells, with an IC50 of 3.0 μM. Akt1-IN-8 can reduce phosphorylated GSK3β levels .
loading...
    loading...
Cat. No.: HY-P80008
Synonyms: Akt 1; Akt; Akt1; Akt1_HUMAN ; MGC99656; PKB; PKB-ALPHA; PRKBA; Protein kinase B Alpha ; Proto-oncogene c-Akt; RAC Alpha;

Host:  

Rabbit

Application:  

IHC-P, IHC-F, ICC/IF, IP, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-E70791
Target:  

Akt

Research Areas:  

Cancer

AKT is the oncogenic protein kinase that regulates essential cellular functions such as migration, proliferation, differentiation, apoptosis, and metabolism. Mammalian cells are characterized by the expression of three different Akt isoforms, Akt1, Akt2, and Akt3. Biotin-AKT2 Recombinant Human Active Protein Kinase is obtained by expressing AKT2 proteins and is biotinylated .
loading...
    loading...
Cat. No.: HY-123390
CAS No.: 552332-71-5
Target:  

Bcr-Abl Akt

Research Areas:  

Cancer

DB07107 is a potent agent resistant T315I mutant Bcr-Abl tyrosine kinase inhibitor. DB07107 is also a potent Akt1 inhibitor with an IC50 value of 360 nM .
loading...
    loading...